Delivery Order SPE2DB22D3004-SPE2DB25FPT80
Award Date
3/4/25
Potential Completion Date
3/5/25
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,057.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EMERPHED 50 MG/10 ML SYRINGE 10ML, a medical product, with a completion date of February 26, 2024. This is a Firm Fixed Price (FFP) Delivery Order contract, and there was no set-aside designation used. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,895.28, is a Delivery Order for the supply of EMERPHED 25 MG/5 ML SYRINGE 5ML, a pharmaceutical product. The contract has a Firm Fixed Price pricing type and a completion date of November 27, 2024. This award is a child contract under a larger Indefinite Delivery Contract (IDC) worth...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract (SPE2DB22D3004|SPE2DB24FPX06) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of EMERPHED 50 MG/10 ML SYRINGE 10ML pharmaceutical products. The $1,312.12 delivery order has an ultimate completion date of April 8, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of EMERPHED 50 MG/10 ML SYRINGE 10ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract is a firm fixed-price delivery order with a ceiling value of $1,972.92 and an ultimate completion date of July 12, 2024. Amerisourcebergen, a major pharmaceutical distribution company, is the prime contractor for this award. The contract is not set aside and was awarded on a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of EMERPHED 50 MG/10 ML SYRINGE 10ML, a critical medical product. It is a firm-fixed price contract with a ceiling value of $1,324.12 and a period of performance through October 8, 2024. The contract does not have a set-aside designation. As a large pharmaceutical supplier, Amerisourcebergen has been awarded numerous...
This federal contract award, valued at $1,968.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of EMERPHED 50 MG/10 ML SYRINGE 10ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of May 9, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,357.44 Firm Fixed Price Delivery Order (SPE2DB22D3004|SPE2DB25FNX72) is for the supply of EMERPHED 50 MG/10 ML SYRINGE 10ML, a pharmaceutical product. The contract has an ultimate completion date of December 24, 2024. Amerisourcebergen maintains a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,832.78, is for the delivery of EMERPHED 50 MG/10 ML VIAL 10ML, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has a completion date of January 2, 2025. This award is not associated with a set-aside designation. Amerisourcebergen...
This is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC), awarded to Amerisourcebergen Drug Corp. for the supply of 4565786556 - EMERPHED 50 MG/10 ML SYRINGE 10ML. The award has a ceiling value of $2,296.21 and a completion date of September 13, 2024. This contract is for the delivery of essential pharmaceutical products to support military treatment facilities and programs. Amerisourcebergen is a major supplier of medical...
This is a federal contract award valued at $2,952.27 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to provide 4564287327 - EMERPHED 50 MG/10 ML SYRINGE 10ML. The contract is a Delivery Order with a Firm Fixed Price pricing type and an Ultimate Completion Date of April 16, 2024. Amerisourcebergen Drug Corp is a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies...